Stay updated on IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.

Latest updates to the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page
- Check4 days agoChange DetectedReplimune, Inc. was added and Replimune Inc. was removed. Revision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision entry v3.5.0 was added to the history and the previous entry v3.4.3 was removed.SummaryDifference0.1%

- Check47 days agoChange DetectedThe history now includes Revision: v3.4.3 and removes Revision: v3.4.2 from the page's history.SummaryDifference0.1%

- Check61 days agoChange DetectedNew entries were added to the record history: 'Study Status' on 2026-02-13 and a value '43' on 2026-02-12, with a deletion recorded on 2025-12-17.SummaryDifference0.2%

- Check68 days agoChange DetectedThe record history now includes a new revision entry: v3.4.2. The previous revision v3.4.1 has been removed from the listing.SummaryDifference0.1%

- Check76 days agoChange DetectedThe history shows a new revision entry (v3.4.1) and removal of the previous v3.4.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.